NATURE BIOTECHNOLOGY

Scope & Guideline

Pioneering Innovations in Life Sciences

Introduction

Welcome to the NATURE BIOTECHNOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of NATURE BIOTECHNOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1087-0156
PublisherNATURE PORTFOLIO
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1989 to 2024
AbbreviationNAT BIOTECHNOL / Nat. Biotechnol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHEIDELBERGER PLATZ 3, BERLIN 14197, GERMANY

Aims and Scopes

Nature Biotechnology focuses on the intersection of biological sciences and technology, emphasizing innovative methodologies and applications that advance our understanding and manipulation of biological systems for therapeutic and industrial purposes.
  1. Genome Editing and Engineering:
    A central theme in the journal is the exploration and advancement of genome editing technologies, particularly CRISPR and its derivatives. This includes the development of novel editing systems that enhance specificity and reduce off-target effects.
  2. Synthetic Biology:
    Nature Biotechnology publishes studies on synthetic biology, which involves designing and constructing new biological parts, devices, and systems. This encompasses the engineering of microbes for applications in medicine, agriculture, and environmental sustainability.
  3. Biotherapeutics and Drug Development:
    The journal frequently features research on the development of biotherapeutics, including monoclonal antibodies, CAR-T therapies, and RNA-based therapeutics. This area focuses on the translation of basic research into clinical applications.
  4. Bioinformatics and Computational Biology:
    Computational approaches to analyzing biological data are a major focus, with studies leveraging machine learning, deep learning, and other computational tools to interpret complex biological datasets.
  5. Microbiome Research:
    Research on the microbiome and its implications for health and disease is increasingly prominent, reflecting a growing interest in understanding host-microbe interactions and their therapeutic potential.
  6. Regenerative Medicine and Stem Cell Technology:
    The journal covers advancements in regenerative medicine, including the use of stem cells for tissue engineering and the development of new therapies for degenerative diseases.
Nature Biotechnology is currently witnessing several emerging themes that reflect the forefront of biotechnological research and innovation, highlighting the journal's adaptability to new scientific advancements.
  1. Advanced Genome Editing Techniques:
    Newly developed genome editing tools, such as prime editing and base editing, are gaining traction. These methods promise greater precision and fewer off-target effects, driving interest in their applications across various fields.
  2. Integration of AI in Biotechnology:
    The application of artificial intelligence and machine learning in biotechnology is rapidly expanding. Researchers are leveraging these technologies for predictive modeling, data analysis, and optimizing biotechnological processes.
  3. Personalized Medicine:
    Research focused on personalized medicine, particularly in the context of cancer and rare diseases, is on the rise. This trend is driven by advancements in genomics and an increasing emphasis on tailored therapeutic approaches.
  4. Sustainability and Environmental Biotechnology:
    There is an emerging focus on biotechnological solutions aimed at addressing environmental challenges, such as bioremediation and sustainable agricultural practices, reflecting a broader societal push towards sustainability.
  5. Cell and Gene Therapies:
    The field of cell and gene therapies is rapidly advancing, with increasing numbers of studies exploring novel therapies and delivery methods, particularly in the context of genetic disorders and cancer treatment.

Declining or Waning

While Nature Biotechnology continues to thrive in many areas, certain research themes have shown signs of waning interest or frequency in publication over recent years.
  1. Traditional Drug Discovery Methods:
    As biotechnology evolves, traditional methods of drug discovery, which rely heavily on high-throughput screening of small molecules, are becoming less prominent. The focus has shifted towards more innovative approaches, such as utilizing AI and machine learning for drug development.
  2. Plant Biotechnology:
    Although still relevant, the frequency of publications specifically focused on plant biotechnology has decreased as the field expands into more integrated approaches combining multiple disciplines such as synthetic biology and gene editing.
  3. Animal Models in Drug Testing:
    There appears to be a decline in studies centered around traditional animal models for drug testing, as researchers increasingly explore alternative methods, including organoids and in vitro systems that better mimic human physiology.
  4. Single-Cell Genomics:
    While single-cell genomics remains important, there is a noticeable shift towards more integrative approaches that combine single-cell data with spatial transcriptomics and proteomics, indicating a transition away from isolated single-cell studies.

Similar Journals

BioImpacts

Championing open access to transformative scientific findings.
Publisher: TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICESISSN: 2228-5652Frequency: 4 issues/year

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.

GEN Biotechnology

Connecting Fundamental Research to Real-World Impact
Publisher: MARY ANN LIEBERT, INCISSN: 2768-1572Frequency: 6 issues/year

GEN Biotechnology, published by MARY ANN LIEBERT, INC, is a pivotal journal dedicated to advancing the field of biotechnology through the dissemination of high-quality research. With its ISSN 2768-1572 and E-ISSN 2768-1556, this journal seeks to bridge the gap between fundamental biotechnology research and its practical applications across various industries. As a leading publication in the life sciences arena, it emphasizes innovative studies in areas such as genetic engineering, molecular biology, bioinformatics, and synthetic biology. Although currently not open access, GEN Biotechnology offers a platform for researchers, professionals, and students to delve into cutting-edge findings that significantly impact health, agriculture, and environmental sustainability. Its commitment to excellence is underscored by its strive for high visibility within the global research community.

Journal of Zhejiang University-SCIENCE B

Connecting Researchers to Transformative Scientific Discoveries
Publisher: ZHEJIANG UNIV PRESSISSN: 1673-1581Frequency: 12 issues/year

The Journal of Zhejiang University-SCIENCE B, published by ZHEJIANG UNIV PRESS, serves as a crucial platform for disseminating groundbreaking research across various fields including Biochemistry, Genetics, Molecular Biology, Medicine, Pharmacology, Toxicology, and Veterinary Science. With an impressive track record since its establishment in 2005, this journal continues to make significant contributions to scientific literature, ranking in the Q1 and Q2 quartiles as of 2023. This indicates its high relevance and impact within its respective fields, evidenced by its outstanding Scopus rankings, including a remarkable 4th position in Veterinary General and Pharmacology, indicating its authoritative voice in the scientific community. Researchers, professionals, and students are encouraged to explore this journal for insights and developments in innovative research, making it an essential resource for those dedicated to advancing the frontiers of science. The journal is accessible through traditional subscription models, ensuring that it remains a reliable source of high-quality research from China and beyond.

PROTEIN EXPRESSION AND PURIFICATION

Elevating Standards in Protein Methodologies
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1046-5928Frequency: 12 issues/year

PROTEIN EXPRESSION AND PURIFICATION, published by Academic Press Inc. Elsevier Science, is a premier journal in the field of biotechnology. With its ISSN 1046-5928 and E-ISSN 1096-0279, the journal has been a vital source of knowledge since its inception in 1990 and continues to provide high-quality research up to 2025. Though categorized in the third quartile (Q3) for 2023 within its scope of biochemistry, genetics, and molecular biology, it serves as a valuable platform for scientists and researchers focusing on the latest advancements in protein expression methodologies and purification techniques. The journal enjoys a respectable Scopus rank of 177 out of 311 in its category, representing a 43rd percentile position that underscores its impact in the research community. While not an Open Access journal, it offers a wealth of insights that can significantly enhance one's understanding of protein biochemistry, making it a must-read for professionals and students alike engaged in this dynamic field.

Cellular and Molecular Bioengineering

Cultivating Knowledge in Molecular and Cellular Innovations
Publisher: SPRINGERISSN: 1865-5025Frequency: 4 issues/year

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

TRENDS IN BIOTECHNOLOGY

Exploring Innovations in Bioengineering
Publisher: CELL PRESSISSN: 0167-7799Frequency: 12 issues/year

TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

Bioengineering-Basel

Shaping Tomorrow's Bioengineering Solutions
Publisher: MDPIISSN: Frequency: 12 issues/year

Bioengineering-Basel, an esteemed journal published by MDPI, stands at the forefront of innovation in the field of bioengineering since its inception in 2014. With an E-ISSN of 2306-5354, this fully Open Access journal based in Switzerland provides a platform for researchers and professionals to disseminate cutting-edge findings across various aspects of bioengineering, including biomaterials, tissue engineering, and biopharmaceuticals. The journal has been recognized with a Q3 ranking in the 2023 Bioengineering category, reflecting its commitment to quality and relevance. By facilitating widespread accessibility to academic knowledge, Bioengineering-Basel aims to foster collaboration and stimulate thought leadership within the global research community, making it an indispensable resource for students, scholars, and industry practitioners alike.

Research Journal of Biotechnology

Exploring the frontiers of biotechnology research.
Publisher: RESEARCH JOURNAL BIOTECHNOLOGYISSN: 2278-4535Frequency: 12 issues/year

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

CYTOTECHNOLOGY

Advancing Cytotechnology: Pioneering Research for Tomorrow's Innovations.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

EuroBiotech Journal

Empowering the Future of Biotechnology with Knowledge
Publisher: SCIENDOISSN: Frequency: 4 issues/year

EuroBiotech Journal, published by SCIENDO, is an essential open-access platform for researchers and professionals in the fields of biomedical engineering, biotechnology, food science, genetics, molecular biology, and molecular medicine. Since its establishment in 2017, the journal has aimed to disseminate high-quality, peer-reviewed research that fosters innovation and collaboration within the European biotechnological landscape and beyond. With its target audience comprising academic scholars, industry practitioners, and students, EuroBiotech Journal has successfully carved a niche, achieving notable Scopus ranks and quartiles, such as Q3 in Biotechnology and Food Science. Based in Warsaw, Poland, the journal welcomes manuscripts that contribute to the vast array of current topics, addressing pressing challenges and discovering solutions pertinent to biotechnology and its applications. As you explore the latest advancements published in this journal, you will find a rich source of knowledge that promotes a deeper understanding of the dynamic and evolving field of biotechnological research.